News

4 skincare ingredients your beauty routine needs – backed by science
With hundreds of skincare products and new ingredients stocking store shelves, it's tough to know what's going to actually ...
Celtics vs Magic Game 1: One Win Down But Jayson Tatum Suffers Injury
The Boston Celtics and Orlando Magic began their first-round playoff series on Sunday, with the Celtics prevailing in Game 1.
Woman's World on MSN4d
Prescription-Strength Skincare for Anti-Aging Delivered to Your Door
Have you ever wondered whether prescription skincare is worth the hype? The answer might be simpler (and more accessible) ...
Ophthalmology Times5d
Regeneron’s sBLA for Eylea HD accepted for priority review by FDA
The sBLA seeks approval for Eylea HD for both the treatment of macular edema following retinal vein occlusion and broadening ...
Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY® and TWYNEO® in the U.S.
Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient ...
Sol-Gel Technologies Ltd.: Sol-Gel and Mayne Pharma Announce the Purchase of EPSOLAY and TWYNEO in the U.S.
Sol-Gel to receive $16 million during 2025Cash runway is expected to extend into the first quarter of 2027; Company expects to have sufficient cash to complete its Phase III clinical trialSGT-610 Phas ...
CURE6d
Breaking Down The Use of Rina-S in Advanced Ovarian Cancer
Dr. Elizabeth K. Lee discusses the RAINFOL-01 clinical trial evaluating treatment with Rina-S in advanced ovarian cancer.
Dermatology Advisor6d
Ruxolitinib 1.5% Cream Significantly Reduces Itch, Lesions in Prurigo Nodularis
Ruxolitinib 1.5% cream significantly reduces pruritus and lesion severity among adults with prurigo nodularis for up to 12 weeks of treatment.